FABP4 and hepatocellular carcinoma: FABP4 expression evaluated by western blotting was significantly higher in HCC from patients with MS without metformin compared to MS patients with metformin or other risk factors, including chronic alcohol consumption or HCV and HBV infection (p < 0.0001) (Fig. 1a).